• Company Type For Profit
  • Contact Email info@bmeye.com
  • Phone Number 31 20 751 2410

BMEYE B.V., a non-invasive cardiovascular monitoring company, engages in the research and development of medical technologies for cardiovascular monitoring in the Netherlands and internationally. It offers finger arterial pressure and cardiac output technologies. The company's products include Finapres, a non-invasive continuous finger blood

pressure monitor; Portapres, an ambulatory non-invasive continuous finger blood pressure monitor for measurements; Finometer, a stationary monitor with options for non-invasive brachial pressure and beat-to-beat hemodynamics; and BeatScope, a software package for the analysis of arterial pressure waveforms. Its products also comprise Modelflow, a model-based measurement method to compute the aortic flow waveform and cardiac outout from an arterial blood pressure waveform; Space instrumentation, a version of finger blood pressure monitors; Cardiopres, an ambulatory device for research on the interaction of electrophysiology, hemodynamics, and respiration; and Oxyflow, a hemodynamics and oxygen delivery monitor for experimental applications. In addition, the company offers Nexfin, a non invasive blood pressure and cardiac output monitor, as well as ccNexfin for applications in various areas, such as cardiology, anesthesiology, sleep observation, physiology, neurology, and internal medicine; and emergency, acute, intensive, and intermediate care. It offers its products through a network of distributors. BMEYE B.V. was founded in 2005 and is based in Amsterdam, the Netherlands.

Lists Featuring This Company

Acquired Medical Device Companies
2,521 Number of Organizations • $47.8B Total Funding Amount • 3,471 Number of Investors
Closed Europe, Middle East, and Africa (EMEA) Health Care Companies
2,028 Number of Organizations • $9.8B Total Funding Amount • 1,357 Number of Investors
Closed Europe, Middle East, and Africa (EMEA) Biotechnology Companies
830 Number of Organizations • $7.4B Total Funding Amount • 1,199 Number of Investors
Closed Europe Health Care Companies
1,742 Number of Organizations • $8.8B Total Funding Amount • 1,155 Number of Investors
BMEYE was acquired by Edwards Lifesciences for €28.4M on Oct 10, 2012. This deal was done in Cash.

Frequently Asked Questions

Where is BMEYE's headquarters? BMEYE is located in Amsterdam, Noord-Holland, The Netherlands.Who invested in BMEYE? BMEYE has 7 investors including Earlybird Venture Capital and 360 Capital.How much funding has BMEYE raised to date? BMEYE has raised .When was the last funding round for BMEYE? BMEYE closed its last funding round on Oct 8, 2009 from a Series B round.Who are BMEYE's competitors? Alternatives and possible competitors to BMEYE may include Phoenix BiotechnologyNovexel, and Planer plc.